Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) EBT Margin (2020 - 2026)

NeuroPace has reported EBT Margin over the past 7 years, most recently at 29.56% for Q1 2026.

  • For Q1 2026, EBT Margin fell 67.0% year-over-year to 29.56%; the TTM value through Mar 2026 reached 21.1%, up 853.0%, while the annual FY2025 figure was 20.98%, 1336.0% up from the prior year.
  • EBT Margin for Q1 2026 was 29.56% at NeuroPace, down from 10.26% in the prior quarter.
  • Over five years, EBT Margin peaked at 10.26% in Q4 2025 and troughed at 123.58% in Q2 2022.
  • A 5-year average of 51.44% and a median of 39.64% in 2024 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: tumbled -7308bps in 2022 and later skyrocketed 6758bps in 2023.
  • Year by year, EBT Margin stood at 86.01% in 2022, then soared by 58bps to 35.89% in 2023, then soared by 33bps to 24.06% in 2024, then soared by 57bps to 10.26% in 2025, then tumbled by -188bps to 29.56% in 2026.
  • Business Quant data shows EBT Margin for NPCE at 29.56% in Q1 2026, 10.26% in Q4 2025, and 13.08% in Q3 2025.